← Open Payments lookup

EMILY WARRICK: Open Payments

NPI 1114559804 · AXTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,518 in 160 payments from 31 companies in 2025. Trend: 2023 $2,713 · 2024 $3,032 · 2025 $2,518

Food & beverage: $2,518
CompanyPaymentsAmount
ABBVIE INC.23$313
Novo Nordisk Inc14$240
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$201
Lilly USA, LLC16$199
Otsuka America Pharmaceutical, Inc.17$199
Lundbeck LLC13$174
AstraZeneca Pharmaceuticals LP7$160
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$115
Phathom Pharmaceuticals, Inc.5$99
Janssen Pharmaceuticals, Inc5$92

Products named: REXULTI, CAPLYTA, MOUNJARO, FARXIGA, XIFAXAN, Ozempic, VOQUEZNA, SPRAVATO.

Industry payments across VA — which companies pay providers there.